Christopher P. Stewart serves as Executive at Bionano Genomics, Inc, where they oversee executive responsibilities. Since joining the company, Christopher P. Stewart has executed 6 insider transactions totaling $33.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on May 12, 2023 involved purchasing 50,000 shares valued at $33.5K.
Christopher P. Stewart currently holds 281,373 shares of Bionano Genomics, Inc (BNGO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher P. Stewart has been a net buyer of BNGO stock. They have purchased $33.5K and sold $0 worth of shares.
Christopher P. Stewart's most recent insider trade was on May 12, 2023, when they purchased 50,000 shares at $0.67 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 13, 2022 | BNGO | $33.6K | Option Exercise | 60,000 | $0.56 | Discretionary |
| Nov 19, 2021 | BNGO | $12.6K | Option Exercise | 22,500 | $0.56 | Discretionary |
| May 26, 2021 | BNGO | $14.0K | Option Exercise | 25,000 | $0.56 | Discretionary |
| Jan 22, 2021 | BNGO | $48.0K | Award | 8,000 | $6.00 | Discretionary |